Heat shock proteins in breast cancer progression- A suitable case for treatment?

International Journal of Hyperthermia

Volumn 26, Issue 7, 2010, Pages 681-685

  Calderwood, Stuart K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Breast; Cancer; Heat; HSF1; Protein; Shock

Indexed keywords

ANSAMYCIN DERIVATIVE; EMUNIN; GENISTEIN; GROWTH FACTOR; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; KNK 437; NOVOBIOCIN; ONCOPROTEIN; PROTEIN INHIBITOR; TANESPIMYCIN; TRIPTOLIDE; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; BREAST CARCINOMA; BREAST CELL; CANCER CELL; CANCER GROWTH; CELL DEATH; CELL DIVISION; CELL TRANSFORMATION; GROWTH STIMULATION; HEAT SHOCK RESPONSE; HUMAN; MUTATION; PROTEIN FAMILY; PROTEIN TARGETING; REVIEW;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HEAT-SHOCK PROTEINS; HUMANS;

EID: 77956933047     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2010.490254     Document Type: Review

References (48)

1. Calderwood SK, Ciocca DR. Heat shock proteins: Stress proteins with Janus-like properties in cancer. Int J Hyperthermia 2008;24:31-39.
2. Lindquist S, Craig EA. The heat shock proteins. Ann Rev Genet 1988;22:631-637.
3. Bukau B, Weissman J, Horwich A. Molecular chaperones and protein quality control. Cell 2006;125:443-451.
4. Subjeck JR, Sciandra JJ, Johnson RJ. Heat shock proteins and thermotolerance: A comparison of induction kinetics. Br J Radiol 1982;55:579-584.
5. Landry J, Bernier D, Chretien P, Nicole LM, Tanguay RM, Marceau N. Synthesis and degradation of heat shock proteins during the development and decay of thermotolerance. Cancer Research 1982;42:2457-2461. (Pubitemid 12121474)
6. Li GC, Werb Z. Correlation between the synthesis of heat shock proteins and the development of thermotolerance in CHO fibroblasts. Proc Natl Acad Sci USA 1982;79:3218-3222.
7. Calderwood SK, Murshid A, Prince T. The shock of aging: Molecular chaperones and the heat shock response in longevity and aging - A mini-review. Gerontology 2009;55:550-558.
8. Tang D, Khaleque MA, Jones EL, Theriault JR, Li C, Wong WH, Stevenson MA, Calderwood SK. Expression ofheat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones 2005;10:46-58.
9. Jones EL, Zhao MJ, Stevenson MA, Calderwood SK. The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer. Int J Hyperthermia 2004;20:835-849.
10. Gabai VL, Meriin AB, Yaglom JA, Volloch VZ, Sherman MY. Role of Hsp70 in regulation of stress-kinase JNK: Implications in apoptosis and aging. FEBS Lett 1998;438:1-4.
11. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and 70: Anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006;5:2592-2601.
12. Sorger PK, Pelham HRB. Yeast heat shock factor is an essential DNA-binding protein that exhibits temperature-dependent phosphorylation. Cell 1988;54:855-864.
13. Wu C. Heat shock transcription factors: Structure and regulation. Ann Rev Cell Dev Biol 1995;11:441-469.
14. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR. Heat shock proteins in cancer: Chaperones of tumorigenesis. Trends Biochem Sci 2006;31:164-172.
15. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103.
16. Ciocca DR, Vargas-Roig LM. Hsp27 as a prognostic and predictive factor in cancer. Prog Mol Subcell Biol 2002;28:205-218.
17. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003;425:407-410.
18. Neckers L, Lee YS. Cancer: The rules of attraction. Nature 2003;425:357-359.
19. Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998;396:336-342.
20. Sangster TA, Salathia N, Lee HN, Watanabe E, Schellenberg K, Morneau K, Wang H, Undurraga S, Queitsch C, Lindquist S. HSP90-buffered genetic variation is common in Arabidopsis thaliana. Proc Natl Acad Sci USA 2008;105:2969-2974.
21. Khaleque MA, Bharti A, Sawyer D, Gong J, Benjamin IJ, Stevenson MA, Calderwood SK. Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene 2005;24:6564-6573.
22. Leav I, Plescia J, Goel HL, Li J, Jiang Z, Cohen RJ, Languino LR, Altieri DC. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol;176:393-401.
23. Wadhwa R, Taira K, Kaul SC. An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: What, when, and where? Cell Stress Chaperones 2002;7:309-316.
24. Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, Ciocca DR, Stati A, Fanelli M, Calderwood SK. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 2008;27:1886-1893.
25. Wang Y, Theriault JR, He H, Gong J, Calderwood SK. Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells. J Biol Chem 2004;279:32651-32659.
26. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007;130:1005-1018.
27. Kawabe M, Mandic M, Taylor JL, Vasquez CA, Wesa AK, Neckers LM, Storkus WJ. Heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17- demethoxygeldanamycin enhances EphA2+ tumor cell recognition by specific CD8+ T cells. Cancer Res 2009;69:6995-7003.
28. Tsutsumi S, Beebe K, Neckers L. Impact of heat-shock protein 90 on cancer metastasis. Future Oncol 2009;5:679-688.
29. Neckers L, Ivy SP. Heat shock protein 90. Curr Opin Oncol 2003;15:419-424.
30. Whitesell L, Lindquist SL. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005;5:761-772.
31. Kim YS, Alarcon SV, Lee S, Lee MJ, Giaccone G, Neckers L, Trepel JB. Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem 2009;9:1479-1492.
32. Gray Jr. PJ, Stevenson MA, Calderwood SK. Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res 2007;67:11942-11950.
33. Gray Jr. PJ, Prince T, Cheng J, Stevenson MA, Calderwood SK. Targeting the oncogene and kinome chaperone CDC37. Nat Rev Cancer 2008;8:491-495.
34. Gurbuxani S, Schmitt E, Cande C, Parcellier A, Hammann A, Daugas E, Kouranti I, Spahr C, Pance A, Kroemer G, et al. Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor. Oncogene 2003;22:6669-6678. (Pubitemid 37372207)
35. Schmitt E, Parcellier A, Gurbuxani S, Cande C, Hammann A, Morales MC, Hunt CR, Dix DJ, Kroemer RT, Giordanetto F, et al. Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis-inducing factor mutant. Cancer Res 2003;63:8233-8240. (Pubitemid 37549473)
36. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Biological and clinical implications of heat shock protein 27,000 (Hsp27): A review. J Natl Cancer Inst 1993;85:1558-1570.
37. Sherman MY, Gabai V, O'Callaghan C, Yaglom J. Molecular chaperones regulate p53 and suppress senescence programs. FEBS Lett 2007;581:3711-3715.
38. Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegen-erative diseases. Neuron 2001;29:15-32.
39. Brunet Simioni M, De Thonel A, Hammann A, Joly AL, Bossis G, Fourmaux E, Bouchot A, Landry J, Piechaczyk M, Garrido C. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene 2009;28:3332-3344.
40. Buchdunger E, Matter A, Druker BJ. Bcr-Abl inhibition as a modality of CML therapeutics. Biochim Biophys Acta 2001;1551:M11-18.
41. Min JN, Huang L, Zimonjic DB, Moskophidis D, Mivechi NF. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors. Oncogene 2007;26:5086-5097.
42. Asea A, Ara G, Teicher BA, Stevenson MA, Calderwood SK. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. Int J Hyperthermia 2001;17:347-356.
43. Price BD, Calderwood SK. Ca2+ is essential for multistep activation of the heat shock factor in permeabilized cells. Mol Cell Biol 1991;11:3365-3368.
44. Martin CA, Kurkowski DL, Valentino AM, Santiago-Schwarz F. Increased intracellular, cell surface, and secreted inducible heat shock protein 70 responses are triggered during the monocyte to dendritic cell (DC) transition by cytokines independently of heat stress and infection and may positively regulate DC growth. J Immunol 2009;183:388-399.
45. Koishi M, Yokota S, Mae T, Nishimura Y, Kanamori S, Horii N, Shibuya K, Sasai K, Hiraoka M. The effects of KNK437, a novel inhibitor of heat shock protein synthesis, on the acquisition of thermotolerance in a murine transplantable tumor in vivo. Clin Cancer Res 2001;7:215-219.
46. Zaarur N, Gabai VL, Porco J, Calderwood SK, Sherman MY. Novel inhibitors of heat shock protein expression sensitize cancer cells to proteasome and hsp90 inhibitors. Cancer Res 66:1783-1791.
47. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-850. (Pubitemid 40558990)
48. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.